£111.99

Academic Press NK Cells in Cancer Immunotherapy: Successes and Challenges (Volume 4) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 4)

Price data last checked 39 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£112 today · previous high £112 · all-time low £15

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 52 days • 52 data points (No recent data available)

Historical
Generating forecast...
£111.99 £5.15 £28.46 £51.77 £75.08 £98.39 £121.70 05 April 2026 17 April 2026 30 April 2026 13 May 2026 26 May 2026

Price Distribution

Price distribution over 52 days • 7 price levels

Days at Price
Current Price
9 days 3 days 5 days 10 days 4 days 9 days 12 days · current 0 3 6 9 12 £15 £17 £21 £22 £26 £31 £112 Days at Price

Price Analysis

Most common price: £112 (12 days, 23.1%)

Price range: £15 - £112

Price levels: 7 different prices over 52 days

Description

NK Cells in Cancer Immunotherapy: Successes and Challenges explains the latest immunotherapeutic strategies, focusing on NK cells to allow the best and precise combination treatments to cancer patients. The book provides existing background knowledge in the field of immunotherapy and discusses future areas of research required to carry out cutting-edge, validated therapies. Chapters cover advances in immunotherapeutic strategies, in particular, the use of NK cells with and without T-cell therapy in the treatment of cancer. The book is a valuable resource for cancer researchers, oncologists, graduate students and those interested in learning more about novel strategies to treat cancer patients. Immunotherapy is fast becoming the method of choice for cancer therapy. Although remarkable advances have been made in the field of immunotherapy, there are significant challenges and difficulties ahead since many of the current immunotherapeutic strategies do not provide long-lasting treatment strategies, and therefore are not very effective. Covers CAR/T and CAR/NK and adoptive NK cell therapy with and without T cell therapies Discusses basic biology of NK cells and mouse models of human cancers and the role of NK cells in metastatic cancer and in cancer stem cells Encompasses information on combination therapies using check point inhibition, adoptive transfer of cytotoxic effector cells, chemotherapeutic drugs and activating and inhibitory antibodies

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
13 December 2022
Listed Since
03 January 2020

Barcode

No barcode data available

Similar Products You Might Like

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
86% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£108.92 10 Jun 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
85% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£111.46 31 May 2026
Natural Killer Cells: At the Forefront of Modern Immunology
84% match

Natural Killer Cells: At the Forefront of Modern Immunology

Springer

£108.92 05 Jun 2026
Natural Killer Cells: At the Forefront of Modern Immunology
83% match

Natural Killer Cells: At the Forefront of Modern Immunology

Springer

£107.98 24 May 2026
Immunotherapy for Gastrointestinal Cancer
83% match

Immunotherapy for Gastrointestinal Cancer

Springer

£99.03 05 Jun 2026
Immunotherapy for Pediatric Malignancies
83% match

Immunotherapy for Pediatric Malignancies

Springer

£113.90 05 Jun 2026
Immuno-Oncology: From Bench to Bedside
83% match

Immuno-Oncology: From Bench to Bedside

CREATESPACE

£82.80 11 Jun 2026
Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)
83% match

Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)

Humana

£107.98 11 Jun 2026
Cancer Immunotherapy: Paradigms, Practice and Promise
83% match

Cancer Immunotherapy: Paradigms, Practice and Promise

Springer

£108.92 30 May 2026
Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy: 9 (Resistance to Targeted Anti-Cancer Therapeutics, 9)
83% match

Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy: 9 (Resistance to Targeted Anti-Cancer Therapeutics, 9)

Springer

£75.14 11 Jun 2026
Experimental and Applied Immunotherapy
82% match

Experimental and Applied Immunotherapy

Humana

£140.31 04 May 2026
Specificity, Function, and Development of NK Cells: NK Cells: The Effector Arm of Innate Immunity: 230 (Current Topics in Microbiology and Immunology, 230)
82% match

Specificity, Function, and Development of NK Cells: NK Cells: The Effector Arm of Innate Immunity: 230 (Current Topics in Microbiology and Immunology, 230)

Springer

£73.96 11 Jun 2026
Natural Killer Cells: Basic Science and Clinical Application
82% match

Natural Killer Cells: Basic Science and Clinical Application

Academic Press

£88.46 31 May 2026
Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)
82% match

Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)

Humana

£103.24 25 May 2026
Cellular Therapies for Cancer Treatment: Advancements in Drug Delivery Strategies
82% match

Cellular Therapies for Cancer Treatment: Advancements in Drug Delivery Strategies

Academic Press

£141.99 30 May 2026
Natural Killer T cells: Balancing the Regulation of Tumor Immunity (Cancer Drug Discovery and Development)
82% match

Natural Killer T cells: Balancing the Regulation of Tumor Immunity (Cancer Drug Discovery and Development)

Humana

£75.68 29 May 2026
Experimental and Applied Immunotherapy
81% match

Experimental and Applied Immunotherapy

Humana

£118.30 04 Jun 2026
Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
81% match

Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal

Springer

£179.99 31 May 2026
Natural Killer Cells: Methods and Protocols: 1441 (Methods in Molecular Biology, 1441)
81% match

Natural Killer Cells: Methods and Protocols: 1441 (Methods in Molecular Biology, 1441)

Humana

£88.17 01 Jun 2026
General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology
81% match

General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology

Springer

£145.54 21 May 2026
Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)
81% match

Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)

Humana

£107.98 29 May 2026
Brain Tumor Immunotherapy
80% match

Brain Tumor Immunotherapy

Humana

£129.72 03 Jun 2026
Regulation of Cancer Immune Checkpoints: Molecular and Cellular Mechanisms and Therapy: 1248 (Advances in Experimental Medicine and Biology, 1248)
80% match

Regulation of Cancer Immune Checkpoints: Molecular and Cellular Mechanisms and Therapy: 1248 (Advances in Experimental Medicine and Biology, 1248)

Springer

£142.76 19 May 2026
Tumor Immunology (Advances in Immunology): Volume 130
80% match

Tumor Immunology (Advances in Immunology): Volume 130

Academic Press

£117.00 22 Jun 2026